Physician

Tami Bach, MD

According to 2025 Medicare claims, Tami Bach, MD (NPI: 1306887245) practices hematology in the Camden, NJ market, with the plurality of this provider's patient population coming from Gloucester, NJ. This provider's primary affiliated billing organization is THE MINNITI CENTER FOR MEDICAL ONCOLOGY AND HEMATOLOGY (NPI: 1831234954; TIN: 221929064) and primary practice location at 08056-1236. Bach is affiliated with the Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Bach's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 427 traditional Medicare patients, billed 179,305 HCPCS/CPT codes, and received $2,043,410 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,008 prescription claims across 175 beneficiaries totaling $4,115,915 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 104 claims. Open Payments data shows 6 records totaling $126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,650,172 to $4,115,915. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $2,833 to $3,673.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	518	101,178	$1,256,955
2016	488	123,575	$1,634,901
2017	532	137,469	$1,577,535
2018	490	140,069	$1,877,434
2019	479	137,449	$1,689,441
2020	425	137,796	$1,423,060
2021	464	187,779	$2,182,189
2022	431	160,010	$1,589,461
2023	437	161,810	$1,745,007
2024	427	179,305	$2,043,410

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	129	810	$1,650,172
2016	157	1,038	$1,713,360
2017	144	899	$1,645,091
2018	149	778	$1,875,873
2019	148	833	$2,204,248
2020	143	930	$2,625,355
2021	161	936	$3,697,124
2022	156	834	$4,099,964
2023	146	854	$3,192,054
2024	175	1,008	$4,115,915

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	46	$20,742
2016	N/R	94	$1,979
2017	N/R	102	$4,659
2018	N/R	53	$1,346
2019	N/R	52	$5,537
2020	N/R	98	$9,543
2021	N/R	165	$6,733
2022	N/R	134	$4,740
2023	N/R	196	$8,409
2024	N/R	104	$4,348

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	263	446	$144
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	235	562	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	105	245	$73
36415	Insertion of needle into vein for collection of blood sample	308	1,322	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	304	1,290	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	64	1,920	$854,872
Revlimid	Lenalidomide	41	1,148	$752,248
Calquence	Acalabrutinib Maleate	28	840	$432,209
Pomalyst	Pomalidomide	14	392	$321,014
Tasigna	Nilotinib Hcl	13	372	$251,809

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	11	$2,006
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	31	$1,091
J9190	Injection, fluorouracil, 500 mg	N	N/R	31	$676
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	31	$575

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$126	Incyte Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tami Bach, MD?

Tedicare shows public-source Medicare data for Tami Bach, MD (NPI 1306887245), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tami Bach, MD have ACO affiliation data?

Tami Bach, MD is shown with ACO affiliation data for Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Tami Bach, MD?

Tami Bach, MD is linked to THE MINNITI CENTER FOR MEDICAL ONCOLOGY AND HEMATOLOGY (billing NPI 1831234954) in the available physician profile data.

Does Tami Bach, MD have Open Payments data?

Tami Bach, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.